Global First and China's First: Century Kangtai's LiangShiAn® Tri-focal Plus IOL Officially Launched

This is a landmark event. The launch of this product marks Century Healthcare's ascent to new heights in the ophthalmology field, successfully placing it among the leading global enterprises in high-end intraocular lenses.Thus far, Tianjin Century Healthcare Biomedical Engineering Co., Ltd. has obtained 11 Class III medical device registration certificates, and this is the second Class III medical device registration certificate of 2025!

Yifeng Zetan Fund participated in 2023Century Healthcare Series B Financing.

LumiVision® All-New Generation Trifocal Plus Intraocular Lens PossessesGlobally pioneering "Intelligent Targeted Light Field Distribution" proprietary patent technology(CN202110610310.5), breaking through existing bottlenecks and颠覆传统的设计理念, adopts an asymmetric design to utilize more diffraction orders, achieving diversified and free adjustment of diffraction orders. The light energy utilization rate reaches 90% or even higher, thereby reducing glare; at the same time, its phase modulation technology can be个性化设计 according to individual vision needs, achieving a smooth transition between far, intermediate, and near vision, and providing comfortable and continuous full-range vision.

The product is designed based on Century Healthcare's innovative Mercury intraocular lens platform.Possesses multiple leading technologies: China's first Monte Carlo optimization - 0.1μm spherical aberration design: This design achieves the maximum balance between a wider depth of focus and contrast sensitivity, further enhancing the clinical application experience of the product;A New Generation of Hydrophobic Acrylic Material First Developed in China: Utilizing a unique "Hydrobalance Technology", after the IOL is implanted in the eye, it gradually saturates to nearly 4% water content, combining both hydrophilic and hydrophobic advantages, achieving the same level as hydrophilic intraocular lenses.The shimmer effect further enhances patient comfort.

On October 13, 2023, the all-new generation trifocal Plus intraocular lens, Liang Shi An®, passed the special review process of the National Medical Products Administration (NMPA) for innovative medical devices. This indicates that the product has gained recognition from national authoritative institutions in terms of technological level, innovative technology, performance, and clinical outcomes, reaching a world-class and leading position in China. As of now, the all-new generation trifocal Plus intraocular lens, Liang Shi An®, is also...The only trifocal intraocular lens innovative medical device approved for marketing in China.

Century Healthcare is a Class III high-end medical device manufacturing enterprise that integrates research and development, production, and sales. Relying on excellent scientific research platforms, and guided by the strategic directive of "Innovative Ophthalmic Materials and Optical Design Platform," Century Healthcare covers areas such as intraocular lenses, optometry, and biomaterials like collagen. It currently has more than 20 products applied in ophthalmology, surgery, and medical aesthetics.

The company has obtained more than 80 invention patents and utility model patents, with 8 Class III medical device registration certificates and 3 Class II medical device registration certificates approved by the National Medical Products Administration. In addition, the company's intraocular lens products have also obtained foreign certifications such as CE certification.

In 2023, Century Healthcare's advanced intraocular lenses such as multifocal and extended depth-of-field, as well as scleral lenses and orthokeratology lenses, have all completed clinical enrollment. The company has become an "innovative ophthalmic materials and optical technology platform enterprise" with a presence in the fields of cataract refractive surgery, optometry, and biomaterials like collagen.

It is currently one of the few enterprises in China's ophthalmology field that simultaneously masters the core technologies of hydrophilic, hydrophobic, monofocal, multifocal intraocular lens optical design, processing, and production. Among these, the "-0.1μm spherical aberration design," "edge-enhanced zero spherical aberration," "hollow haptics," and "625 large optical zone" are all domestic firsts for aspheric intraocular lenses in China; its collagen sponge product has even obtained the first Class III medical device registration certificate for full surgical use of collagen sponge approved by the National Medical Products Administration under the new standards since 2011.